Novel prokinetic agents have shown initial promise in clinical trials, and new endoscopic techniques such as gastric per-oral endoscopic myotomy are emerging
Patients who have been told to "just live with it" are understandably open to trying something that offers a plausible biological mechanism and a sense of agency, even without a full evidence base
therefore, DUPIXENT may be transmitted from the mother to the developing fetus
This innovative treatment synergistically combines a fully human monoclonal antibody, aimed at the GIP receptor (GIPR) a target for blood sugar control with a GLP-1 agonist peptide analog , which is a molecule designed to stimulate insulin release [Vniant, M.M
You can reduce severity by building good nutrition habits before treatment begins
Long-term progress develops over several months with regular follow-up